Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
Mac-1 (CR3) 和 Fc gamma 受体在免疫介导的中性粒细胞细胞毒性中的作用
基本信息
- 批准号:7582061
- 负责人:
- 金额:$ 39.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:4-ethoxymethylene-2-phenyl-2-oxazoline-5-oneAdhesivesAntibodiesAntigen-Antibody ComplexAttenuatedAutoimmune DiseasesAutoimmune ProcessAutoimmune hemolytic anemiaBindingBiochemicalBiological AssayBullous PemphigoidC3biClinical TrialsComplementCoupledCutaneous InvolvementDataDepositionDermalDiseaseEnsureErythrocytesExhibitsFamilyFamily memberFundingGenerationsGlomerulonephritisGlucansGoalsGrantGuanineGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHemolytic AnemiaHemorrhagic VasculitisHost DefenseHost Defense MechanismITAMIgG ReceptorsImmuneImmunityImmunocompromised HostImmunoglobulin GImmunosuppressionIn VitroInfectionInflammatoryInflammatory ResponseInjuryIntegrinsLeadLeukocyte ElastaseLinkMacrophage-1 AntigenMediatingModelingMolecularMycosesMyelogenousNADPH OxidaseNeutrophil InfiltrationOrganPathologyPathway interactionsPhagocytesPhagocytosisPhagosomesPharmaceutical PreparationsPhospholipase CPhospholipase DPhosphorylationPhosphotransferasesPhysiologicalPlayPredispositionProcessProtein FamilyProtein Kinase CProtein Tyrosine KinaseProteinsProteomicsReactive Oxygen SpeciesRegulationRelative (related person)Respiratory BurstRheumatismRoleShwartzman PhenomenonSignal PathwaySignal TransductionSignaling MoleculeTherapeuticTissuesTransducersTreatment EfficacyVariantVasculitisbasecombatcomparativecytotoxiccytotoxicitydectin 1designglomerular basement membranehuman SYK proteinhuman diseasein vitro Assayin vivoin vivo Modelinterestmacrophagemicrobialnatalizumabneutrophilneutrophil cytosol factor 40Kopsonin receptorparticleprotein functionpublic health relevancerac GTP-Binding Proteinsreceptorresponserhorho GTP-Binding Proteinsskin disordersrc-Family Kinasestherapeutic developmenttherapeutic targettooltraffickinguptake
项目摘要
DESCRIPTION (provided by applicant): Phagocytic functions of neutrophils and macrophages are essential for immunity to microbial infection, but can also contribute to tissue injury during inflammatory responses and autoimmune pathologies. The overall goal of this application is to continue to extend our understanding of the molecular basis of phagocyte cytotoxicity focusing on two major opsonic receptors on phagocytes, Fc?Rs (receptors for IgG immune complex) and the ¿2 integrin Mac-1 (receptor for complement fragment iC3b). Major accomplishments of the past 4 years were to 1) demonstrate that Vav proteins, exchange factor for Rho GTPase family members are required for several Mac-1 and Fc?R mediated adhesive functions in neutrophils, 2) identify Vav proteins as the major signal transducers of NADPH oxidase activation following Fc?R engagement, through regulation of Rac GTPases and phosphorylation of the NADPH oxidase p40phox, 3) present in vivo evidence that neutrophil Fc?R dependent but not complement dependent tissue injury requires Vav and Rac proteins, 4) define a role for Mac-1 in triggering neutrophil elastase release and subsequent hemorrhagic vasculitis in vivo, through activation of the src and syk kinases, and 5) demonstrate a critical role for Mac-1 on neutrophils in two additional complement dependent models, bullous pemphigoid and thrombotic glomerulonephritis. The current application builds on these discoveries. The objective of Aim I is to delineate mechanisms of neutrophil phagocytosis that are relevant for complement C3 mediated tissue injury and host defense. In particular we will examine both signals that lead to Mac-1 binding of its target and those that link Mac-1 to downstream effector functions. In Aim II, we will further delineate mechanisms of Vav mediated regulation of the NADPH oxidase following Fc?R engagement in neutrophils and macrophages. We will also clarify the role of Vav and Rac in IgG or complement mediated phagocytosis in macrophages in models of autoimmune hemolytic anemia. We anticipate that the completion of our aims should lead to a better understanding of signaling pathways that link opsonic receptors to specific phagocyte cytotoxic functions. This may aid in the design of therapeutics to selectively target pathways responsible for tissue damage in inflammatory and autoimmune disorders while minimizing effects on host defense.
PUBLIC HEALTH RELEVANCE: The objective of this proposal is to understand the neutrophil dependent mechanisms that mediate injury to the dermal microvasculature, a well-recognized target of autoimmune damage that contributes to end organ/skin disease. For example, the inflammatory destruction of the vessel wall, vasculitis, is observed in autoimmune rheumatic diseases with cutaneous involvement being the most common, and neutrophil accumulation being a common feature. Drugs such as natalizumab, which interferes with neutrophil trafficking have demonstrated marked therapeutic efficacy in autoimmune diseases, but also exhibited potentially fatal immunosuppression. In this application we propose to delineate signaling pathways that potentially promote microvascular tissue damage, but are not required for neutrophil recruitment. This could lead to the identification of targeted therapeutic strategies that attenuate organ injury while minimally immunocompromising the host.
描述(由申请人提供):中性粒细胞和巨噬细胞的吞噬功能对于微生物感染的免疫至关重要,但也可能导致炎症反应和自身免疫病理过程中的组织损伤。本申请的总体目标是继续扩展我们对微生物感染的理解。吞噬细胞细胞毒性的分子基础,重点关注吞噬细胞上的两种主要调理受体:Fc?R(IgG 免疫复合物的受体)和 ¿ 2 整合素 Mac-1(补体片段 iC3b 的受体) 过去 4 年的主要成就是 1) 证明 Vav 蛋白(Rho GTPase 家族成员的交换因子)是多种 Mac-1 和 Fc?R 介导的粘附功能所必需的。在中性粒细胞中,2) 通过调节 Rac GTPases 和 Fc?R 接合,确定 Vav 蛋白是 Fc?R 参与后 NADPH 氧化酶激活的主要信号转导子NADPH 氧化酶 p40phox 的磷酸化,3) 体内证据表明中性粒细胞 Fc?R 依赖性而非补体依赖性组织损伤需要 Vav 和 Rac 蛋白,4) 定义了 Mac-1 在触发中性粒细胞弹性蛋白酶释放和随后的出血性血管炎中的作用体内,通过激活 src 和 syk 激酶,5) 证明 Mac-1 对中性粒细胞的关键作用两个额外的补体依赖性模型,大疱性类天疱疮和血栓性肾小球肾炎当前的应用建立在这些发现的基础上,目的是描述与补体 C3 介导的组织损伤和宿主防御相关的中性粒细胞吞噬机制。导致 Mac-1 与其靶标结合的信号以及将 Mac-1 与下游效应器功能联系起来的信号。在 Aim II 中,我们将进一步描述 Vav 的机制。我们还将阐明 Vav 和 Rac 在自身免疫性溶血性贫血模型中巨噬细胞中 IgG 或补体介导的吞噬作用中的作用。导致更好地理解将调理受体与特定吞噬细胞细胞毒性功能联系起来的信号通路,这可能有助于设计选择性靶向通路的治疗方法。负责炎症和自身免疫性疾病中的组织损伤,同时最大限度地减少对宿主防御的影响。
公共健康相关性:本提案的目的是了解介导真皮微脉管系统损伤的中性粒细胞依赖性机制,真皮微脉管系统是公认的导致终末器官/皮肤疾病的自身免疫损伤的目标,例如血管的炎症破坏。血管壁炎,血管炎,常见于自身免疫性风湿性疾病,其中皮肤受累是最常见的,中性粒细胞积聚是常见特征,例如药物。那他珠单抗干扰中性粒细胞运输,在自身免疫性疾病中具有显着的治疗功效,但也表现出潜在的致命性免疫抑制作用。在本申请中,我们建议描绘出可能促进微血管组织损伤的信号通路,但这些信号通路对于中性粒细胞募集来说不是必需的。确定有针对性的治疗策略,以减轻器官损伤,同时最大限度地减少宿主的免疫功能受损。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tanya N Mayadas其他文献
Tanya N Mayadas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tanya N Mayadas', 18)}}的其他基金
Neutrophil plasticity in autoimmune disease
自身免疫性疾病中的中性粒细胞可塑性
- 批准号:
10326852 - 财政年份:2020
- 资助金额:
$ 39.37万 - 项目类别:
Neutrophil plasticity in autoimmune disease
自身免疫性疾病中的中性粒细胞可塑性
- 批准号:
10569637 - 财政年份:2020
- 资助金额:
$ 39.37万 - 项目类别:
TNFR2 Regulation of Leukocyte Recruitment in Glomerulonephritis
肾小球肾炎中白细胞募集的 TNFR2 调节
- 批准号:
8821615 - 财政年份:2014
- 资助金额:
$ 39.37万 - 项目类别:
TNFR2 Regulation of Leukocyte Recruitment in Glomerulonephritis
肾小球肾炎中白细胞募集的 TNFR2 调节
- 批准号:
9456733 - 财政年份:2014
- 资助金额:
$ 39.37万 - 项目类别:
cAMP Control of Endothelial Barrier and T Cell Migration
cAMP 控制内皮屏障和 T 细胞迁移
- 批准号:
7753048 - 财政年份:2009
- 资助金额:
$ 39.37万 - 项目类别:
Endothelia mechanisms of leukocyte accumulation in glomerulonephritis
肾小球肾炎白细胞积聚的内皮机制
- 批准号:
7903751 - 财政年份:2009
- 资助金额:
$ 39.37万 - 项目类别:
Endothelia mechanisms of leukocyte accumulation in glomerulonephritis
肾小球肾炎白细胞积聚的内皮机制
- 批准号:
7620123 - 财政年份:2007
- 资助金额:
$ 39.37万 - 项目类别:
Endothelia mechanisms of leukocyte accumulation in glomerulonephritis
肾小球肾炎白细胞积聚的内皮机制
- 批准号:
7322748 - 财政年份:2007
- 资助金额:
$ 39.37万 - 项目类别:
Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
Mac-1 (CR3) 和 Fc gamma 受体在免疫介导的中性粒细胞细胞毒性中的作用
- 批准号:
8209095 - 财政年份:2003
- 资助金额:
$ 39.37万 - 项目类别:
相似国自然基金
聚电解质络合作用调控的高初黏性大豆蛋白粘合剂构建及增强机制研究
- 批准号:52303059
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
氮杂环丙烷基聚多硫化物可逆粘合剂的分子设计与制备
- 批准号:22378080
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
仿深共晶溶剂小分子类低温粘合剂的设计制备及粘附机制研究
- 批准号:22308299
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多酚功能化壳聚糖基组织粘合剂构建及其能量耗散机制探究
- 批准号:82302389
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于短肽诱导蚕丝蛋白组装的可控粘附生物粘合剂的制备及粘附性能研究
- 批准号:52303272
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Bio-Responsive and Immune Protein-Based Therapies for Inhibition of Proteolytic Enzymes in Dental Tissues
用于抑制牙齿组织中蛋白水解酶的基于生物响应和免疫蛋白的疗法
- 批准号:
10555093 - 财政年份:2023
- 资助金额:
$ 39.37万 - 项目类别:
Localized mitochondrial metabolic activity in Xenopus mesendoderm cells undergoing collective cell migration
爪蟾中内胚层细胞集体细胞迁移的局部线粒体代谢活性
- 批准号:
10751722 - 财政年份:2023
- 资助金额:
$ 39.37万 - 项目类别:
FimH-Targeting Antibody-Recruiting Molecules as Novel Drugs for Preventing Complicated Urinary Tract Infections
FimH 靶向抗体招募分子作为预防复杂性尿路感染的新药
- 批准号:
10603693 - 财政年份:2023
- 资助金额:
$ 39.37万 - 项目类别:
Optimization of protective antibodies response against bacterial adhesins
针对细菌粘附素的保护性抗体反应的优化
- 批准号:
10731509 - 财政年份:2023
- 资助金额:
$ 39.37万 - 项目类别:
Identifying Mechanisms Involved in Hydroxyurea-Mediated Reduction in Vaso-occlusive Adhesive Events in Sickle Cell Disease
确定羟基脲介导的镰状细胞病血管闭塞性粘附事件减少机制
- 批准号:
10724590 - 财政年份:2023
- 资助金额:
$ 39.37万 - 项目类别: